NCT06846528View on ClinicalTrials.gov

A Study to Investigate the Pharmacokinetics of AZD2389 When Administered Alone and in Combination With Itraconazole in Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

16

Participants

Timeline

Start Date

February 26, 2025

Primary Completion Date

April 23, 2025

Study Completion Date

April 23, 2025

Conditions

Healthy Participants

Interventions

DRUG

AZD2389

AZD2389 is administered orally

DRUG

Itraconazole

Itraconazole is administered orally

Trial Locations (1)

21225

Research Site, Brooklyn

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors

collaborator

Parexel

INDUSTRY

lead

AstraZeneca

INDUSTRY